The principal aim of the project is to conduct an off-label adjunctive clinical trial
evaluating varenicline as a treatment for core neurobiological and clinical deficits in
schizophrenia, in addition to evaluating for smoking cessation in schizophrenia patients.
Phase:
Phase 4
Details
Lead Sponsor:
University of Maryland University of Maryland, Baltimore